I6XD65 | PNCA_MYCTU | Nicotinamidase/pyrazinamidase | pyrazinamide
| Abrogated prodrug activation | 275 | 12 | 145 |
P9WNF9 | ETHA_MYCTU | FAD-containing monooxygenase EthA | ethionamide
| Abrogated prodrug activation | 237 | 0 | 428 |
P9WGY9 | RPOB_MYCTU | DNA-directed RNA polymerase subunit beta | rifampicin
| Drug target alteration | 122 | 8 | 535 |
P9WGW9 | RSMG_MYCTU | Ribosomal RNA small subunit methyltransferase G | streptomycin
| Abrogation of drug target methylation | 118 | 3 | 359 |
P9WIE5 | KATG_MYCTU | Catalase-peroxidase | isoniazid
| Abrogated prodrug activation | 112 | 2 | 641 |
P9WJ63 | TLYA_MYCTU | 16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA | capreomycin
| Abrogation of drug target methylation | 29 | 0 | 60 |
P9WNL7 | EMBB_MYCTU | Probable arabinosyltransferase B | ethambutol
| Drug target alteration | 14 | 8 | 625 |
P9WG47 | GYRA_MYCTU | DNA gyrase subunit A | levofloxacin, moxifloxacin
| Drug target alteration | 9 | 8 | 362 |
P9WG45 | GYRB_MYCTU | DNA gyrase subunit B | levofloxacin, moxifloxacin
| Drug target alteration | 5 | 3 | 252 |
P9WH63 | RS12_MYCTU | Small ribosomal subunit protein uS12 | streptomycin
| Unclear | 4 | 0 | 30 |
P9WP15 | DDN_MYCTU | Deazaflavin-dependent nitroreductase | delamanid
| Abrogated prodrug activation | 1 | 0 | 33 |
P9WGR1 | INHA_MYCTU | Enoyl-[acyl-carrier-protein] reductase [NADH] | ethionamide, isoniazid
| Drug target alteration | 1 | 0 | 81 |
P9WH87 | RL3_MYCTU | Large ribosomal subunit protein uL3 | linezolid
| Drug target alteration | 1 | 0 | 19 |
P9WFK7 | EIS_MYCTU | N-acetyltransferase Eis | amikacin, kanamycin
| Abrogation of drug inactivating enzyme | 0 | 1 | 129 |
O06393 | O06393_MYCTU | Possible cytochrome C-type biogenesis protein CcsA | amikacin, capreomycin
| Unclear | 0 | 2 | 90 |
P9WQB7 | AHPC_MYCTU | Alkyl hydroperoxide reductase C | isoniazid
| Unclear | 0 | 0 | 69 |
P9WPS1 | ATPL_MYCTU | ATP synthase subunit c | bedaquiline
| Drug target alteration | 0 | 0 | 8 |
P9WMC1 | ETHR_MYCTU | HTH-type transcriptional regulator EthR | ethionamide
| Gene regulation | 0 | 0 | 67 |
P9WIN9 | MP64_MYCTU | Immunogenic protein MPT64 | bedaquiline, clofazimine
| Unclear | 0 | 0 | 45 |
P95160 | NDH_MYCTU | Type II NADH:quinone oxidoreductase Ndh | ethionamide, isoniazid
| Overabundance of drug target substrate | 0 | 0 | 187 |
O05882 | O05882_MYCTU | Conserved protein | pyrazinamide
| Unclear | 0 | 0 | 61 |
O53582 | AFTB_MYCTU | Terminal beta-(1->2)-arabinofuranosyltransferase | amikacin, capreomycin
| Unclear | 0 | 2 | 190 |
P9WF37 | WHIB6_MYCTU | Probable transcriptional regulator WhiB6 | amikacin, capreomycin, streptomycin
| Gene regulation | 0 | 1 | 184 |
P9WIQ1 | GLF_MYCTU | UDP-galactopyranose mutase | ethambutol
| Unclear | 0 | 0 | 1 |
P9WNF7 | MYMA_MYCTU | Putative FAD-containing monooxygenase MymA | ethionamide
| Unclear | 0 | 0 | 158 |
P9WJV1 | MMPL5_MYCTU | Siderophore exporter MmpL5 | bedaquiline, clofazimine
| Drug efflux | 0 | 3 | 224 |
P9WGT3 | MABA_MYCTU | 3-oxoacyl-[acyl-carrier-protein] reductase MabA | ethionamide, isoniazid
| Unclear | 0 | 0 | 102 |
P9WH35 | RS4_MYCTU | Small ribosomal subunit protein uS4 | rifampicin
| Unclear | 0 | 1 | 79 |
P9WNE1 | FGD_MYCTU | F420-dependent glucose-6-phosphate dehydrogenase | delamanid
| Abrogated prodrug activation | 0 | 0 | 40 |
P9WFR5 | DPPRS_MYCTU | Decaprenyl-phosphate phosphoribosyltransferase | amikacin, capreomycin, ethambutol
| Unclear | 0 | 3 | 128 |
P9WKW7 | Y3788_MYCTU | Uncharacterized protein Rv3788 | ethambutol
| Unclear | 0 | 0 | 3 |
P9WN87 | FURA_MYCTU | Transcriptional regulator FurA | isoniazid
| Gene regulation | 0 | 3 | 111 |
P9WIL3 | PAND_MYCTU | Aspartate 1-decarboxylase | pyrazinamide
| Drug target alteration | 0 | 0 | 25 |
Q79FI8 | Q79FI8_MYCTU | PPE family protein PPE35 | pyrazinamide
| Unclear | 0 | 4 | 139 |
O53487 | O53487_MYCTU | DUF2784 domain-containing protein | pyrazinamide
| Unclear | 0 | 1 | 0 |
P9WIQ3 | FPRA_MYCTU | NADPH-ferredoxin reductase FprA | amikacin, capreomycin
| Unclear | 0 | 1 | 168 |
P9WNL9 | EMBA_MYCTU | Probable arabinosyltransferase A | ethambutol
| Drug target alteration | 0 | 9 | 545 |
P9WJX9 | TAP_MYCTU | Multidrug efflux pump Tap | isoniazid, pyrazinamide, streptomycin
| Drug efflux | 0 | 0 | 216 |
P9WPC9 | CLPC1_MYCTU | ATP-dependent Clp protease ATP-binding subunit ClpC1 | pyrazinamide
| Unclear | 0 | 2 | 60 |
L7N665 | L7N665_MYCTU | Probable conserved integral membrane transport protein | pyrazinamide
| Drug efflux | 0 | 3 | 112 |
P9WMY7 | MSHA_MYCTU | D-inositol 3-phosphate glycosyltransferase | ethionamide, isoniazid
| Abrogated prodrug activation | 0 | 0 | 192 |
O33195 | O33195_MYCTU | Uncharacterized protein | capreomycin
| Unclear | 0 | 0 | 18 |
I6Y8F7 | MMPR5_MYCTU | HTH-type transcriptional regulator MmpR5 | bedaquiline, clofazimine
| Gene regulation | 0 | 0 | 116 |
P9WGZ9 | RNJ_MYCTU | Ribonuclease J | rifampicin, isoniazid
| Unclear | 0 | 6 | 402 |
Q6MX01 | WHB7A_MYCTU | Probable transcriptional regulator WhiB7 | amikacin, kanamycin, streptomycin
| Gene regulation | 0 | 0 | 53 |
P9WP81 | FBIA_MYCTU | Phosphoenolpyruvate transferase | delamanid
| Unclear | 0 | 0 | 56 |
O33194 | G3PP_MYCTU | D-glycerol 3-phosphate phosphatase | capreomycin
| Unclear | 0 | 0 | 11 |
P9WHG1 | RF2_MYCTU | Peptide chain release factor 2 | amikacin, capreomycin
| Unclear | 0 | 0 | 9 |
P9WQM5 | Y1979_MYCTU | Uncharacterized transporter Rv1979c | bedaquiline, clofazimine
| Drug efflux | 0 | 0 | 141 |
P9WNL5 | EMBC_MYCTU | Probable arabinosyltransferase C | ethambutol
| Drug target alteration | 0 | 8 | 446 |
P9WGJ9 | EMBR_MYCTU | Transcriptional regulatory protein EmbR | ethambutol
| Gene regulation | 0 | 2 | 218 |
P9WN03 | AFTA_MYCTU | Galactan 5-O-arabinofuranosyltransferase | ethambutol
| Unclear | 0 | 10 | 437 |
P9WGZ1 | RPOA_MYCTU | DNA-directed RNA polymerase subunit alpha | rifampicin
| Unclear | 0 | 1 | 94 |
P9WJS7 | MMPS5_MYCTU | Siderophore export accessory protein MmpS5 | bedaquiline, clofazimine
| Drug efflux | 0 | 0 | 33 |
O53789 | Y681_MYCTU | Uncharacterized HTH-type transcriptional regulator Rv0681 | streptomycin
| Gene regulation | 0 | 1 | 2 |
P9WP77 | FBIC_MYCTU | FO synthase | delamanid
| Abrogated prodrug activation | 0 | 0 | 90 |
P9WP79 | FBIB_MYCTU | Bifunctional F420 biosynthesis protein FbiB | delamanid
| Abrogated prodrug activation | 0 | 0 | 52 |
P9WMS9 | AGBR_MYCTU | Arabinogalactan biosynthesis recruiting protein Rv3789 | ethambutol
| Unclear | 0 | 0 | 6 |
P9WH67 | RS10_MYCTU | Small ribosomal subunit protein uS10 | linezolid
| Unclear | 0 | 0 | 26 |
I6YDN6 | I6YDN6_MYCTU | Probable cytoplasmic peptidase PepQ | bedaquiline, clofazimine
| Unclear | 0 | 0 | 57 |
P9WKV1 | Y485_MYCTU | Transcriptional regulator Rv0485 | ethionamide, isoniazid
| Gene regulation | 0 | 0 | 157 |
O06394 | O06394_MYCTU | Probable conserved transmembrane protein | amikacin, capreomycin
| Unclear | 0 | 0 | 23 |
P9WP83 | FBID_MYCTU | Phosphoenolpyruvate guanylyltransferase | delamanid
| Unclear | 0 | 0 | 27 |
P9WJM1 | MURA_MYCTU | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | amikacin, capreomycin, kanamycin, linezolid, streptomycin
| Unclear | 0 | 0 | 10 |
P9WGY7 | RPOC_MYCTU | DNA-directed RNA polymerase subunit beta' | rifampicin
| Unclear | 0 | 9 | 285 |
P9WPV7 | ATP6_MYCTU | ATP synthase subunit a | bedaquiline
| Drug target alteration | 0 | 0 | 2 |